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Feature selectionAbstract Understanding how human cardiomyocytes mature is crucial to realizing stem cell-based
heart regeneration, modeling adult heart diseases, and facilitating drug discovery. However, it is not
feasible to analyze human samples for maturation due to inaccessibility to samples while cardiomy-
ocytes mature during fetal development and childhood, as well as difficulty in avoiding variations
among individuals. Using model animals such as mice can be a useful strategy; nonetheless, it is not
well-understood whether and to what degree gene expression profiles during maturation are shared
between humans and mice. Therefore, we performed a comparative gene expression analysis of mice
and human samples. First, we examined two distinct mice microarray platforms for shared gene
expression profiles, aiming to increase reliability of the analysis. We identified a set of genes display-
ing progressive changes during maturation based on principal component analysis. Second, we
demonstrated that the genes identified had a differential expression pattern between adult and ear-
lier stages (e.g., fetus) common in mice and humans. Our findings provide a foundation for further
genetic studies of cardiomyocyte maturation.Introduction
Pluripotent stem cells (PSCs) hold tremendous potential for
regenerative medicine, disease modeling, and drug discovery
in a broad spectrum of tissue and cell types, such as cardiomy-
ocytes [1–4]. Recent advances in the field have renderedefficient and robust differentiation of cardiomyocytes from
most of PSC lines [5–7]. Although the maturation of differen-
tiated cardiomyocytes into the adult-like stage is essential to
study adult-onset diseases in vitro, fully matured cardiomy-
ocytes have never been obtained [8]. Moreover, there are no
clear-cut and definitive markers available to evaluate car-
diomyocyte maturation [8]. Therefore, a detailed understand-
ing of the cardiac maturation process in vivo is a prerequisite
for further development of methods to maturate PSC-derived
cardiomyocytes in vitro.
Uosaki et al. examined the detailed process of mice cardiac
maturation using meta-microarray analysis [9]. This and other
studies demonstrated that the maturation of cardiomyocytes isnces and
208 Genomics Proteomics Bioinformatics 14 (2016) 207–215a continuous process occurring during embryonic and postna-
tal development [9–12]. Because of limited human samples
obtained during the early life (potentially collected from
aborted fetus, babies that died from accidents or other medical
reasons, and/or biopsies from transplanted hearts) and techni-
cal difficulty in repetitive sample collection from the same indi-
vidual, it is difficult to dissect the progression in humans from
individual variations, e.g., by measuring gene expression.
Therefore, studies of cardiac maturation rely heavily on model
animals, e.g., mice. Here, the key question remain to be
addressed is whether and to what extent cardiac maturation
progresses are similar in mice and humans.
Comparative gene expression analysis [13] is a useful strat-
egy to evaluate consistency between species. It enables study-
ing multiple human diseases in mice, which are hard to
investigate directly in humans [14]. It can even help us to
understand gene regulatory mechanisms in mammals using
gene expression data from non-mammalian animals [15].
Moreover, it also helps in identifying highly-correlative
expression profiles between putative orthologs across species
[16].
In this study, we demonstrated the correlation of gene
expression involved in cardiac maturation between mice and
humans. We performed a meta-microarray analysis of data
generated from mice samples ranging from the embryonic to
the adult stages using two microarray platforms (Affymetrix
Mouse Genome 430 2.0 Array, referred to as ‘‘mouse 430
2.0” hereafter and Mouse Gene 1.0 ST Array, referred as
‘‘mogene 1.0” hereafter) to collect a reliable set of genes corre-
lating with the progression of cardiac maturation in mice. Sub-
sequently, we evaluated whether highly-correlative expression
profiles that were identified in the mice gene set exist in human
samples.Results
Performance comparison between frozen robust microarray
analysis and microarray suite 5 method
In our previous paper [9], we employed the frozen robust
microarray analysis (fRMA) [17] to analyze the gene expres-
sion profiles of more than 200 microarray datasets ranging
from early embryonic to adult hearts. fRMA serves as a reli-
able platform to perform meta-microarray analysis [17].
Nonetheless, fRMA can only be applied to popular microarray
platforms, such as mouse 430 2.0 and mogene 1.0, due to its
requirement of preprocessed dataset. In addition, there is
uncertainty on whether fRMA correctly performs batch effect
extraction, although this is one of the primary reasons why
fRMA is introduced. On the other hand, microarray suite 5
method (MAS5) is a method used for single-microarray pre-
processing [18]. We hypothesized that MAS5 can replace
fRMA for meta-microarray analysis.
To evaluate the performance of MAS5 for data preprocess-
ing, we collected 646 microarray datasets (Table S1) and pre-
processed them with MAS5 as well as fRMA. To allow
comparison, MAS5-processed data was log2 transformed
and scaled (mean = 0; standard deviation = 1). Signal intensi-
ties of all 45,101 probesets on mouse 430 2.0 platform werewell correlated between MAS5 and fRMA (R= 0.90; Pearson
correlation) (Figure 1A). Although probes with medium signal
intensities (6–12 in fRMA) showed better correlation, more
variability was observed for probes with lower or higher signal
intensities. To evaluate whether this variability would compro-
mise the overall analysis, we conducted principal component
analysis (PCA) for signal intensities of preprocessed data by
fRMA (Figure 1B) and MAS5 (Figure 1C). The scatter plots
of the first and second principal component (PC1 and PC2)
values were almost identical. In addition, variable loadings
for PC1 were well correlated between data preprocessed by
fRMA and MAS5 (R= 0.89; Pearson correlation) (Fig-
ure 1D). These results suggest that MAS5 can replace fRMA
for meta-microarray analysis. Therefore, data preprocessed
by MAS5 were used for downstream analyses. As pointed
out previously [9], PC1 represents the maturation process
and PC2 seems to separate batch effects in either preprocessing
method.
As PCA indicated a gradual maturation process in the heart
[9], we next assessed how gene expression changes during the
maturation process. To detect gross changes, we averaged
the signal intensities of each probe at each developmental stage
for ranking. Figure 1E depicts the distribution of the intensity
ranks. As expected, the majority of probesets at the early
embryonic and adult stages ranked either first or fifth, whereas
more than one third of the probes at the late embryonic stage
ranked third, suggesting that the expression of each gene
changes gradually and unidirectionally. This finding is impor-
tant when considering the limited datasets of human heart
samples, which are mostly early-gestation fetal and adult sam-
ples, for comparative genomics.
Probe–gene conversion
To perform comparative gene expression analysis, it is neces-
sary to convert probesets to genes. In mouse 430 2.0, there
were more than 45,000 probesets for 20,736 genes. We used
mouse 4302.db to annotate probesets to genes. As a result,
11,076 genes were annotated to single probesets, whereas the
remaining genes were annotated to at least two probesets (Fig-
ure 2A). Seita et al. reported that identifying probes with the
most dynamic ranges can be a good way to select probes
[19]. However, such a method might be vulnerable to noise.
Therefore, we decided to choose probes based on the
interquartile ranges (IQRs) rather than the full dynamic
ranges. For instance, myomesin 2 (Myom2), encoding an
M-protein that is expressed in mature cardiomyocytes [20],
was annotated to 4 different probesets (Figure 2B). One probe-
set (1438372_at) showed a very small dynamic range, whereas
the other three probesets displayed similar but distinct pat-
terns, with the widest IQR observed for the 1457435_x_at
probeset. Different from Myom2, Slc2a1that encodes glucose
transporter 1 (Glut1) was annotated to 3 probesets (Fig-
ure 2C), which share similar IQRs. In contrast to mouse 430
2.0, more than 95% (19,925 out of 20,915 in total) of genes
were annotated to a single probeset in mogene 1.0 when using
mogene10sttranscriptcluster.db to annotate probesets to genes
(Figure 2D). Therefore, for the mogene 1.0 data, we simply
averaged the signal intensities from multiple probesets to
obtain the expression level of a particular gene.
Figure 1 Comparison of MAS5 and fRMA for mouse 430 2.0 array data preprocessing
A.Hex Bin scatter plot of individual probe sets, obtained from 646 microarray and 45,101 probesets. MAS5 preprocessed, log2-converted,
and scaled data are presented on X-axis, whereas fRMA-preprocessed data are presented on Y-axis. The number of probesets in each hex
bin is color-coded as shown in the figure. Scatter plots are presented for PC scores of PCA for fRMA-preprocessed data (B) and MAS5-
preprocessed, log2-converted and scaled data (C). Samples at each developmental stage are represented in green (early embryo), black (mid
embryo), orange (late embryo), blue (neonate) and red (adult), respectively. D. Hex Bin scatter plot of variable loadings for PC1 in PCA
with MAS5- and fRMA-preprocessed data. The number of probesets in each hex bin is color-coded as shown in the figure. E. Histograms
of ranked probe counts for each developmental stage. fRMA, frozen robust microarray analysis. PCA, principal component analysis.
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using PCA
Next, we used PCA to identify genes associated with cardiac
maturation in mice. As shown in Figure 1C with probe-level
PCA, PCA clearly distinguished the samples from different
stages (Figure 3A). Neonatal samples were grouped into two
clusters. Notably, one neonatal cluster close to the late embry-
onic stage and the other cluster close to the adult stage
included samples from postnatal day (P)3 and P7, respectively,
supporting the notion that PC1 is an explanatory variable for
cardiac maturation. Similarly, we also performed PCA for the
mogene 1.0 data (Figure 3B). For some unknown reasons, data
for some samples from a single institute were widely divergent
from the other datasets. Therefore, these samples were
excluded from entire analysis (data not shown, marked as
‘‘GSI” in Table S2). Although the number of samples for each
stage was small and plots were sparse, the overall patterns for
PCA plots were similar between the mouse 430 2.0 array data
and mogene 1.0 data.
To identify genes associated with cardiac maturation, we
first plotted PC1 loadings of each gene for mouse 430 2.0
and mogene 1.0 data (Figure 3C). The loadings were wellcorrelated (R= 0.78). Next, we added the individual loadings
for each gene. As the summed loadings followed a normal dis-
tribution (data not shown), we selected genes with loadings
higher than mean + 2 standard deviation (SD) and lower than
mean - 2SD as genes that are significantly associated with car-
diac maturation (colored in blue and red, respectively, in
Figure 3C). As more than 3600 genes were unique to either
array (Figure 3D), we also determined significant genes for
each of the two arrays (Figure 3E and F). In total, we identified
648 genes, including 293 and 355 genes associated with mature
and immature status, respectively (full lists available in
Table S3).
Characterization of the maturation-associated genes
A linear model was employed to examine whether the genes
identified above followed the trajectory of maturation (Fig-
ure 1E). First, we averaged the signal intensities of genes across
samples of certain stages, which changed gradually with pro-
gressing stages for both mouse 430 2.0 (Figure 4A) and mogene
1.0 (Figure 4B). We next conducted the linear regression anal-
ysis for each gene to obtain P values and calculated false
discovery rates (FDRs) in order to adjust for multiple
1438175_x_at
1438372_at
1450917_at
1457435_x_at
1426599_a_at
1426600_at
1434773_a_at
Nu
m
be
r o
f g
en
es
1457435_x_at 1426599_a_at
Identify the highest IQR
probeset for each gene
Nu
m
be
r o
f g
en
es
1 2 3-5 5-10 10-20 20-50 50-100
Probesets/gene
19925
779
159
29 17
5
1
A
B  Myom 2 C  Slc2a1
D
Signal intensity (log)
N
o.
 o
f a
rra
ys
4 6 8 10 12 14
4 6 8 10 12 14
4 6 8 10 12 14
4 6 8 10 12 14
6 8 10 12
6 8 10 12
6 8 10 12
1 2 3 4 5 6 7 8 9 10 11-15
Probesets/gene
11076
5287
2393
1132
465
238
95
29
14
3 4
10000
5000
1000
500
100
50
10
5
10000
1000
100
10
1
Mouse 430 2.0
Mogene 1.0
Figure 2 Probeset-to-gene symbol conversion
A. Histogram showing the numbers of probesets annotated to
single genes on the mouse 430 2.0 array. X-axis is numbers of
probesets per gene and Y-axis is shown in logarithmic scale.
Distribution of signal intensities and numbers of arrays for each
probeset corresponding to Myom2 (B) and Slc2a1 (C), respec-
tively. X-axis indicates the log2-transformed signal intensity of
gene expression, whereas the numbers of arrays for the genes are
shown on Y-axis. D. Histogram showing the numbers of probesets
annotated to single genes on the mogene 1.0 array. X-axis is
numbers of probesets per gene and Y-axis is on the logarithmic
scale. IQR, interquartile range; Myom2, myomesin 2; Slc2a1,
solute carrier family 2 (facilitated glucose transporter), member 1.
210 Genomics Proteomics Bioinformatics 14 (2016) 207–215comparisons. Approximately 98% and 89% of the identified
genes in the mouse 430 2.0 and mogene 1.0 arrays, respectively,
had an FDR< 0.10, suggesting linear gene expression alter-
ations for most of the genes identified.
To further characterize biological properties of the identi-
fied genes, we performed KEGG pathway analysis with
DAVID [21,22]. Pathways with an FDR< 0.01 were consid-
ered significant (nodes in color, Figure 4C and D, Table S4
and S5). For the genes associated with immature status,
ribosome- and cell cycle-related (e.g., DNA replication and
oocyte meiosis) pathways were significantly enriched(mmu03010: ribosome; mmu04110: cell cycle, Figure 4C,
Table S4). On the other hand, for the genes associated with
mature status, oxidation and mitochondria-related pathways
(mmu05012: Parkinson’s disease; mmu00190: oxidative phos-
phorylation; mmu05010: Alzheimer’s disease; mmu05016:
Huntington’s disease; mmu00020: citrate cycle or TCA cycle)
and cardiac pathways (mmu04260: cardiac muscle contraction;
mmu05414: dilated cardiomyopathy, DCM, and mmu05410:
hypertrophic cardiomyopathy (HCM)) were significantly
enriched (Figure 4D, Table S5). Taken together, these findings
indicate that the genes identified are associated with cardiac
maturation.Comparison with human datasets
Finally, we assessed the expression patterns of the genes iden-
tified in mice in human datasets. We found two distinct data-
sets of human hearts including fetal and adult hearts
(GSE62913 and GSE71148) [22,23]. GSE62913 contains
RNA-seq data obtained from fetal ventricles and atria, as well
as adult hearts. We performed PCA with all genes as well as
with the maturation-associated genes, respectively. Among
the 648 maturation-associated mice genes identified above,
we found human counterparts of 520 genes in the GSE62913
dataset (234 and 286 for mature and immature status, respec-
tively). PCA with all genes as well as with maturation-
associated genes similarly revealed distinctive patterns between
fetal samples and adult hearts (Figure 5A and B). The other
dataset GSE71148 is an Illumina HumanHT-12 V4.0 expres-
sion beadchip dataset for fetal and adult heart samples. We
identified 586 maturation-associated genes conserved between
humans and mice (262 and 324 for mature and immature sta-
tus, respectively). Consistent with the PCA on GSE62913,
PCA on GSE71148 with all genes or the maturation-
associated genes both generated patterns distinctive between
fetal and adult samples (Figure 5C and D).
To assess whether gene expression patterns in mice and
humans are correlated and whether the usage of maturation-
associated genes improves the correlation over the usage of
all genes, we compared expression changes in mice and
humans using all genes or the maturation-associated genes
only (Figure 5E–H). As the human fetal heart samples were
from fetus in the first and second trimesters (7–20 weeks), we
used early embryonic mice hearts for comparison. We found
that expression changes between adult and early embryo/fetus
using all genes showed good correlation between mice and
humans for mouse 430 2.0 dataset (R= 0.49, Figure 5E) and
mogene 1.0 dataset (R= 0.51, Figure 5G). Nonetheless, the
gene expression changes of maturation-related genes alone
showed better correlation for both datasets (R= 0.73 for
mouse 430 2.0, Figure 5F and R= 0.78 for mogene 1.0, Fig-
ure 5H). Overall, 286 out of 324 immature status-associated
genes and 237 out of 262 mature status-associated genes
showed higher expression in fetal and adult hearts, respec-
tively. Interestingly, most of the genes that showed inconsis-
tency with the findings in mice did not show significant
differences between fetal and adult heart samples in humans
(only 8 genes showing more than 1.5-fold changes,
Table S6). It is of note that MYH7 was among the
immature-associated genes identified in the mice, and was
highly expressed in human adult hearts as is widely known.
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Figure 3 Selection of genes associated with cardiac maturation
PCA scatter plots for all genes in mouse 430 2.0 (A) and mogene 1.0 arrays (B) are shown. Samples at each developmental stage are
represented in green (early embryo), black (mid embryo), orange (late embryo), blue (neonate) and red (adult), respectively. Open circles in
panel B represent adult atrial samples. C. Scatter plots and histograms for PC1 loadings of genes for mouse 430 2.0 (X-axis) and mogene
1.0 (Y-axis) data. PC1 loadings of each gene from both arrays were added and genes outside of the mean ± 2SD of summed PC1 loadings
were selected as maturation-associated genes. Red and blue spots represent genes associated with mature status (mean  2SD) and
immature status (mean + 2SD), respectively, whereas as genes with expression changes between mean + 2SD and mean  2SD are
indicated in black. Histograms on X- and Y-axes depict the distribution of selected genes in the respective arrays. Gene numbers are shown
on a logarithmic scale. D. Venn diagram of annotated genes on the mouse 430 2.0 and mogene 1.0 arrays. Histograms of PC1 loadings of
unique genes on the mouse 430 2.0 or mogene 1.0 arrays are shown in panels E and F, respectively. Genes with mean ± 2SD of respective
PC1 loadings are colored in red and blue.
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tion between early embryonic/fetal and adult stages is mostly
consistent across species, and the maturation-related genes
identified in mice can be mostly recapitulated in humans.Discussion
In this study, we identified cardiac maturation-associated
genes in mice based on PCA of data from two distinct mice
microarrays. We demonstrated that the expression of the genesidentified change progressively during maturation and that the
expression patterns are well conserved between mice and
humans. Although mice and human adult cardiomyocytes
are different in terms of cell size, length of action potential,
and beating rate, etc., they share some common features e.g.,
morphology, abundant mitochondria, and sarcomere structure
[8]. Our findings indicate that mice and humans follow a sim-
ilar maturation process. MYH6 and MYH7, the genes encod-
ing alpha and beta myosin heavy chains, are differentially
expressed in mice and humans. Myh6 encodes a predominant
form of myosin heavy chain in adult mice heart and Myh7 is
Figure 4 Characterization of the genes associated with cardiac maturation
Box plots of mean signal intensities of each gene at different developmental stages for mouse 430 2.0 or mogene 1.0 arrays are shown in
panels A and B, respectively. Red and blue boxes indicate the maturation-associated and immature stage-related genes, respectively.
KEGG pathway networks for genes associated with immature status and mature status are shown in panels C and D, respectively.
Colored nodes indicate FDR< 0.01, while gray nodes indicate FDR> 0.01 among the KEGG pathway enriched in the identified genes.
Nodes are colored as follows: cardiac (red), oxidation (blue), mitochondria function and metabolism (green), cell cycle (orange), ribosome
(yellow). DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; ARVC, arrhythmogenic right ventricular cardiomyopa-
thy; TCA, tricarboxylic acid cycle; PPAR, peroxisome proliferator-activated receptor.
212 Genomics Proteomics Bioinformatics 14 (2016) 207–215expressed in embryonic mice heart, whereas opposite expres-
sion pattern of these two genes is found in humans [24,25].
In accordance herewith, our comparative gene expression anal-
ysis successfully identified thatMYH7 is a gene associated with
immature stage in mice, but highly upregulated in human adult
hearts.
Cells derived from either mice model or mice/human PSCs
are often used for maturation studies. However, PSC-derived
cardiomyocytes barely mature [9]. More importantly, there
are no established readouts to define maturation status of car-
diomyocytes. Structural and functional readouts, which
include cell size, morphology, t-tubule formation, calcium han-
dling, action potential, and mitochondrial function, are often
used [26–28]. It is known how morphology and structure
change during maturation in mice or rat but it is unknown
for human. Physiological features were only studied for adult
cardiomyocytes but not for embryonic and neonatal cardiomy-
ocytes. Therefore, these readouts cannot be used to measure
maturation status quantitatively at this point. The gene list
we provided (Table S3) could serve as a resource for develop-
ing defined, objective, and reliable readouts, as expression of
these genes change monotonically during maturation in both
mice and humans.
As we used PCA-based gene selection and made a compar-
ison only between the adult and early embryonic/fetal stages,
some of the highly differentially-expressed genes shown in Fig-
ure 5E and G were not selected based on PCA. Thus, we took
an alternative approach for gene selection to evaluate whetherthe genes that are highly differentially expressed between adult
and early embryo/fetus are sufficient to recapitulate the heart
maturation pattern. Briefly, we summed the human and mice
differential signal intensities of each gene. As the summed dif-
ferential signal intensities followed a normal distribution, we
selected genes for which expression levels fell out of the range
of mean ± 2SD (Figure S1A and S1B). Although only one
third of the alternatively selected genes overlapped with the
genes selected using the PCA-based method (Figure S1C and
S1D), the PCA patterns generated with the alternatively
selected genes were similar to those generated with all genes
(Figure S1E–H). As we demonstrated in Figure 1E as well as
Figure 4A and B, the maturation process in the heart is unidi-
rectional, and most genes related to maturation changed pro-
gressively. Therefore, the genes highly differentially expressed
between the adult and early embryoic/fetal stages successfully
represented the maturation process, which would be more
appropriate for finding specifically-expressed genes. PCA
granted unidirectional change and would be more appropriate
for studying the process of maturation.
Finally, in this study, we also tackled a bioinformatics
issue—the limitations of fRMA. Although fRMA was
designed to avoid batch effects by using frozen data sets gen-
erated from a large quantity of datasets, fRMA did not outper-
form MAS5, which is a single array-based normalization
method. Our results demonstrate that the performance of
fRMA is correlated well with that of MAS5, suggesting that
MAS5 can be used in place for fRMA.
Figure 5 Comparison of mice datasets with human datasets
Scatter plots for PC scores of different datasets are generated with all genes or the maturation-related genes. Scatter plots for GSE62913
using all genes or just the maturation-related genes are shown in panels A and B, respectively, while for GSE71148, C and D indicate the
plots generated using all genes or the maturation-related genes, respectively. Adult heart samples are indicated with red circle, while fetal
ventricle (Fetal V) and fetal atrium (Fetal A) samples are indicated with circle and triangle in blue, respectively. Scatter plots for
expression changes between human GSE 71148 and mice datasets are shown in panels E–H using all genes or just maturation-associated
genes. Comparison between GSE 71148 and mouse 430 2.0 was conducted using all genes (E) or maturation-related genes (F). Similarly,
comparison between GSE 71148 and mogene 1.0 was conducted using all genes (G) or maturation-related genes (H). Differential signal
intensities for gene expression between early embryonic/fetal stage and adult stage were used. Linear regression lines are also plotted. X
axes indicate gene expression changes (differences of log2-transformed scaled signal intensities) from early embryonic to adult stages in the
respective mice arrays, while Y axes indicate gene expression changes from fetus to adult stage in human GSE71148.
Uosaki H and Taguchi Y-h /Comparing Cardiac Maturation in Mouse and Human 213Conclusions
In this study, we performed a comparative gene expression
analysis of mice and human cardiac maturation. As a result,
we identified more than 500 genes that share distinct expres-
sion patterns during cardiac maturation between mice and
humans. These genes could be further explored for their poten-
tial as genetic markers to investigate cardiomyocyte matura-
tion in future.Methods
mRNA expression
All mRNA expression profiles analyzed in this study were
downloaded from the Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/). Mouse 430 2.0 gene
expression profile was selected from profiles analyzed in our
previous study [9]. Detailed information about mouse 430
2.0 and mogene 1.0 arrays is listed in Tables S1 and S2, respec-
tively. Profiles analyzed in Figures 1, 3 and 4 were generated
from five developmental stages with sample numbers (N) pro-
vided for mouse 430 2.0 and mogene 1.0, respectively. These
include early embryonic (embryonic day (E)8–11, N= 16
and 12), mid embryonic (E12–15, N= 39 and 4), late embry-
onic (E16–18, N= 26 and 2), neonate (postnatal day (P)1–10,N= 16 and 2), and adult (>4-week old, N= 115 and 134)
stages. Only wild-type and non-treated samples were included
in the current study. Human gene expression profiles were
taken from GSE62913 and GSE71148. GSE62193 contains
RNA-seq data for human PSC-derived cells, as well as fetal
and adult hearts, whereas GSE71148 comes from an Illumina
array transcriptome study for 20 samples from fetal and adult
hearts, including Ref-pool (GSM1828516).
Preprocessing
Multiple preprocessing methods were employed in this study.
‘‘MAS5-scale” indicates scaling was performed after MAS5
preprocessing, while ‘‘MAS5-log2-scale” indicates that a log2
transformation was performed before scaling but after
MAS5 preprocessing.
fRMA
fRMA was conducted using the Bioconductor/R fRMA
package. Annotation packages mouse4302frmavecs and
mogene.1.0.st.v1frmavecs were used for mouse 430 2.0 and
mogene 1.0 arrays, respectively.
MAS5
MAS5 normalization was conducted for mouse 430 2.0 and
mogene 1.0 data by using the MAS5 function in the Biocon-
ductor/R affy and xps packages, respectively.
214 Genomics Proteomics Bioinformatics 14 (2016) 207–215Scaling and log2 transformation
Scaling, which extract means and normalize standard devia-
tion to one, was performed with the scale function in R. Addi-
tionally, log2 transformation was also performed using R.
Probeset–gene conversion
To convert probesets to genes, we identified probesets with the
highest IQRs of signal intensity for mouse 430 2.0. To deter-
mine the IQR, we analyzed 429 arrays for brain, 212 arrays
for heart, 142 arrays for kidney, and 137 arrays for liver. All
arrays were preprocessed with fRMA and the IQR was deter-
mined for each probeset. The probe–gene match list was used
to convert MAS5-preprocessed data. The conversion table is
available as Table S7. As only less than 5% of genes were
annotated to multiple probesets in mogene 1.0 (Figure 2D),
we simply averaged the signal intensities of multiple probesets
for a particular gene.
Human datasets
Read count data ofGSE62193were scaled to normalize the indi-
vidual samples (mean = 1 and standard deviation = 0), while
normalized and log2-transformed data for GSE71148 was
directly obtained fromGEOandused for subsequent analysis.
PCA
PCA was conducted using the prcomp function in R to demon-
strate overall differences of samples.
Identification of maturation-associated genes
Maturation-associated genes were identified using two differ-
ent approaches. For genes common to the mouse 430 2.0
and mogene 1.0 arrays, PC1 loadings of each array were
summed. Genes with summed PC1 loadings more than a
mean + 2SD or less than a mean  2SD were selected as
maturation-associated genes. On the other hand, for genes
unique to either of arrays, genes with PC1 loadings more than
a mean + 2SD or less than a mean  2SD of the correspond-
ing array were selected.
Developmental stage wide coarse-grained gene expression analysis
In this analysis, we employed MAS5 preprocessed profiles gen-
erated from the mouse 430 2.0 array. Average of expression of
the i-th gene at each developmental stage, xis, was defined as
xis  1Ns
P
j2sxij where s is one of five aforementioned
developmental stages and Ns is the number of samples that
belong to the stage, xij is expression of the i-th gene in j-th sam-
ples. Averaged values were subsequently ranked across stages.Linear regression analysis of developmental-stage coarse-grained
gene expression
Regression analysis was done using the following equation:
xis = ais + bi, where ai and bi are the regression coefficients,
and s takes values 1–5 corresponding to the developmental
stages in the order of early, mid, late, neonatal, and adult,
respectively. The linear regression analysis was carried out
using lm function in R [29]. P values were adjusted to meetFDR criterion using the fdrtool function in the fdrtool [30]
package. Regressions with q values (adjusted P values) <0.1
were regarded to be significant.
KEGG pathway enrichment analysis
Enrichment analysis for KEGG pathways was performed by
uploading gene symbols to DAVID. Numbers of genes
overlapping between KEGG pathways were used as weights
togenerateKEGGpathwaynetworks shown inFigure 4CandD
with the igraph [31] package in R [29].
Mapping of mice genes to human genes
Identical official gene symbols found in mice and human
data were considered as a pair and used for comparison in
Figure 5.
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